Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 297.00 | |
25 mg | 6-8 weeks | $ 987.00 | |
50 mg | 6-8 weeks | $ 1,360.00 | |
100 mg | 6-8 weeks | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | 6-8 weeks | $ 365.00 |
Description | Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death. |
Targets&IC50 | CDC7 (1 mM ATP):0.6 nM |
Molecular Weight | 409.82 |
Formula | C21H16ClN3O4 |
CAS No. | 1402055-25-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.2 mg/mL (12.69 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cdc7-IN-1 1402055-25-7 Cell Cycle/Checkpoint CDK Cdc7 IN 1 Cdc7IN1 Cdc-7-IN-1 inhibitor inhibit